Abstract
Purpose of Review
Hypercalcemia is commonly seen as a chronic disorder which can be effectively managed in the outpatient world. Acute decompensation of hypercalcemia is a condition that needs urgent evaluation and treatment, otherwise, can become life-threatening. In majority of cases, hyperparathyroidism and malignancy are the causes.
Recent Findings
Thorough history and examination can provide us clues to delineate the cause of hypercalcemia. PTH is the mainstay blood testing that can point us further towards the diagnostic approach. This evaluation is usually done while the patient is being treated to lower down Ca levels with IV hydration, calcitonin, and bisphosphonates.
Summary
Hypercalcemic crisis can require more aggressive approach such as surgical exploration of the neck and emergent parathyroidectomy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med. 2000;342:177–85.
• Bilezikian JP. Clinical review 51: Management of Hypercalcemia. J Clin Endocrinol Metab. 1993;77:1445. Review article which talks in great length about both inpatient and outpatient management options for all degrees of hypercalcemia
Solomon BL, Schaaf M, Smallridge RC. Psychologic symptoms before and after parathyroid surgery. Am J Med. 1994;96:101–6.
Burtis WJ, Wu TL, Insogna KL, Stewart AF. Humoral hypercalcemia of malignancy. Ann Intern Med. 1988;108:454.
Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res. 1991;6(Suppl 2):S51.
Binstock ML, Mundy GR. Effect of calcitonin and glucocorticoids in combination on the hypercalcemia of malignancy. Ann Intern Med. 1980;93:269–72.
•• Ziegler R. Hypercalcemic crisis. J Am Soc Nephrol. 2001;12(suppl 17):S3–9. This article gives detailed insight into the consequences of severe hypercalcemia and the need for aggressive management. It is a recent article with uptodate information regarding the management options
Body JJ. Hypercalcemia of malignancy. Semin Nephrol. 2004;24:48.
LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med. 2008;149:259.
Austin LA, Heath 3rd. H. Calcitonin: physiology and pathophysiology. N Engl J Med. 1981;304:269.
Deftos LJ, First BP. Calcitonin as a drug. Ann Intern Med. 1981;95:192.
Carano A, Teitelbaum SL, Konsek JD, et al. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest. 1990;85:456.
• Stewart AF. Hypercalcemia associated with cancer. N Engl J Med 2005; 352:373. Most recent article about the most common cause of inpatient hypercalcemia. It is a very informative article talking specifically about the mechanism of actions of different treatment agents.
Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med. 1997;103:134–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Diabetes and Metabolic Disease
Rights and permissions
About this article
Cite this article
Minhas, P.S., Virdi, J.K. Hypercalcemia in Inpatient Setting: Diagnostic Approach and Management. Curr Emerg Hosp Med Rep 5, 5–10 (2017). https://doi.org/10.1007/s40138-017-0126-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40138-017-0126-5